Evidence map›Paper›PMID 38580734›Full record

ArticleScientific reports2024

Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma.

S Draye-Carbonnier, V Camus, S Becker, D Tonnelet, E Lévêque, A Zduniak, F Jardin, H Tilly, P Vera, P Decazes

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. The Predictive Role of BaselineDiagnostics (Basel, Switzerland) · 2025
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

S Draye-CarbonnierDepartment of Nuclear Medicine, Centre Henri Becquerel, Rouen, France.
V CamusDepartment of Hematology, Centre Henri Becquerel, Rouen, France.
S BeckerDepartment of Nuclear Medicine, Centre Henri Becquerel, Rouen, France.
D TonneletDepartment of Nuclear Medicine, Centre Henri Becquerel, Rouen, France.
E LévêqueDepartment of Statistics and Clinical Research Unit, Centre Henri Becquerel, Rouen, France.
A ZduniakDepartment of Hematology, Centre Henri Becquerel, Rouen, France.
F JardinDepartment of Hematology, Centre Henri Becquerel, Rouen, France.
H TillyDepartment of Hematology, Centre Henri Becquerel, Rouen, France.
P VeraDepartment of Nuclear Medicine, Centre Henri Becquerel, Rouen, France.
P DecazesDepartment of Nuclear Medicine, Centre Henri Becquerel, Rouen, France. pierre.decazes@chb.unicancer.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prognostic value of radiomic quantitative features measured on pre-treatment

Indexed as

Lymphoma, FollicularPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18HumansPrognosisRetrospective StudiesTumor BurdenFluorodeoxyglucose F1818F-FDG PET/CTFollicular lymphomaPrognosisRadiomicsTumor burden

Identifiers

PMID38580734
PMCPMC10997640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.